Market Size Estimation Methodology:

A detailed market estimation approach was followed to estimate and validate the size of the global Fertility Test Market and other dependent submarkets.

# The key players in the global fertility test market were identified through secondary research, and their global market shares were determined through primary and secondary research.

# The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global fertility test market.

# All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.

# All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Projected Revenue Growth:

The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432

Driver: Increasing first-time pregnancy age

Over the last few decades, the average age of first-time pregnancy has increased drastically across the globe owing to the decline in first births among teenage women and the increase of first births among women aged over 30 years. According to the OECD, the average age at which women give birth now stands at 30 or above; this trend is majorly being observed as women across the globe are showcasing a greater preference for postponing first-time pregnancies.

Restraint: Lesser precision of ovulation prediction kits

Ovulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24–36 hours prior to ovulation. These kits, however, cannot accurately confirm ovulation. In conditions such as luteinized unruptured follicle syndrome (in which a woman’s egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results. Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.

Challenge: High cost of fertility testing monitors

Price and brand recognition are two important criteria for the adoption of fertility testing kits and monitors across the globe. Being elective and non-reimbursable in nature, the price of a device is a prime determinant for its use. Although advanced branded fertility monitors possess high accuracy in identifying the fertility window, they are priced at a premium due to the high costs involved in maintaining brand loyalty, obtaining regulatory approvals, and incorporating the software in the systems. Owing to the high cost of these fertility monitors, a very limited number of patients in developing countries can afford them. This, in turn, is limiting the acceptance of these products, mainly in developing countries.

Opportunity: Emerging nations to offer new growth avenues

Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities to players operating in the fertility test market. The demand for fertility and ovulation monitors in emerging countries is expected to grow significantly in the coming years due to the rising infertility rates, increasing prevalence of PCOS and obesity, growing fertility education, and easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops/drugstores. In addition, friendly regulatory policies and less competition among players in developing markets (as compared to developed markets) have encouraged companies to focus on emerging countries.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432

The home care settings segment is expected to register the highest CAGR during the forecast period

Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

North America dominated the global fertility test market in 2020

North America, comprising the US and Canada, accounted for the largest share of the fertility test market in 2020. The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.